Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celladon Corp (NASDAQ:CLDN)

1.11
Delayed Data
As of Feb 05
 -0.03 / -2.63%
Today’s Change
1.00
Today|||52-Week Range
28.25
-24.49%
Year-to-Date
No recent news for Celladon Corp.

Today’s Trading

Previous close1.14
Today’s open1.14
Day’s range1.10 - 1.15
Volume54,236
Average volume (3 months)649,226
Market cap$26.5M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-61.48%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.36

Competitors

 Today’s
change
Today’s
% change
CHEKCheck Cap Ltd+0.22+10.70%
TEARTearLab Corp-0.02-2.31%
CGNTCogentix Medical Inc-0.03-2.26%
SSHSunshine Heart Inc+0.02+1.83%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 28, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$33.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Financial Officer
Andrew C. Jackson
Vice President-
Clinical Operations
Jeffrey J. Rudy
Corporate headquarters
San Diego, California

Forecasts

Partner Offers